Under construction – not a live service
Sign in
Not yet taking people in EgyptNo phase

Optokinetic stimulation for spatial neglect and balance after stroke

Tests moving visual stimulation for neglect and balance in people after a stroke.

Plain-language title generated from the registry record
Registry title: Effect of Optokinetic Stimulation on Spatial Neglect and Postural Stability in Patients With Stroke

Key facts

Where
Banī Suwayf, EgyptSee the site

Could this be for you?

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 50 and 65 years old?

Source: NCT07424105, who can take part

Where in Egypt

  • Nahda UniversityBanī Suwayf, EgyptNo longer taking part

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
Cairo University
Trial code
NCT07424105
Record updated
20 February 2026
Original description
The purpose of this study is to investigate the efficacy of optokinetic stimulation in stroke patients by examining its effects on spatial neglect, static balance, dynamic balance, and weight-bearing symmetry.Read full original descriptionShow less

Effect of Optokinetic Stimulation on Spatial Neglect and Postural Stability in Patients With Stroke

The purpose of this study is to investigate the efficacy of optokinetic stimulation in stroke patients by examining its effects on spatial neglect, static balance, dynamic balance, and weight-bearing symmetry.

Inclusion: Patient's age ranges from 50 to 65 years referred by neurologist; Patient's will be diagnosed as stroke in the subacute stage; Patients will suffer from spatial neglect resulting from the stroke that screened by albert's test; Patients are medically stable and able to understand and follow instructions.

Exclusion: There is any previous neurological disability; There is general unstable conditions, history of epilepsy, cardiac pacemakers; There is sever cognitive disorder; There is visual field deficit.

ClinicalTrials.gov NCT07424105